|
Market Closed -
Swiss Exchange
11:30:11 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 127.90 CHF | -1.05% |
|
+2.65% | +16.53% |
| 10-25 | Novartis Reports Positive Results from Late-stage Studies for Remibrutinib | MT |
| 10-23 | Novartis AG - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.54% | +1.31% | +7.60% | +6.47% | +18.50% | +54.27% | +117.14% | +419.67% | +1,537.89% | 1,135B | |
| -1.42% | +3.23% | -2.73% | +0.16% | +27.48% | +38.56% | +74.05% | +60.78% | +131.49% | 635B | |
| +0.16% | +0.08% | +8.06% | +10.13% | +25.01% | +25.29% | +96.64% | +163.26% | +364.08% | 505B | |
| -0.31% | +3.09% | +8.49% | +10.08% | +19.10% | +44.14% | +64.55% | +9.42% | +71.30% | 378B | |
| -1.34% | -0.47% | -2.36% | +10.83% | +38.01% | +66.04% | +40.18% | +77.90% | +134.50% | 358B | |
| -0.68% | +2.65% | +6.84% | +0.87% | +16.79% | +22.98% | +49.15% | +66.19% | +76.43% | 295B | |
| -1.20% | +3.04% | +3.42% | +1.22% | -7.01% | +2.33% | +22.86% | +42.55% | +164.36% | 266B | |
| -1.79% | +1.57% | +5.95% | +16.81% | +34.20% | +50.56% | +61.40% | +111.56% | +178.20% | 237B | |
| -0.73% | -0.10% | +3.39% | +20.67% | +27.13% | +29.02% | +99.06% | +130.59% | +109.70% | 193B | |
| -1.74% | +0.21% | +2.83% | -18.86% | -20.02% | -23.95% | -62.43% | -23.63% | +87.90% | 172B | |
| -1.28% | +1.52% | +4.74% | +22.37% | +20.60% | +21.28% | -2.28% | -30.41% | -6.97% | 171B | |
| -2.10% | +4.84% | -0.43% | +9.76% | +15.57% | +24.33% | +44.32% | +183.22% | +565.65% | 133B | |
| -2.41% | +2.90% | -2.20% | -0.98% | +13.98% | +40.27% | +8.60% | +6.35% | +24.08% | 126B | |
| -1.14% | -0.41% | +15.48% | +19.01% | +22.00% | +24.84% | +120.92% | +382.42% | +531.40% | 117B | |
| -1.04% | +1.69% | +0.91% | -1.33% | +3.81% | +16.91% | +28.84% | +6.64% | -7.67% | 102B | |
| -1.11% | +3.03% | +3.25% | -2.51% | -10.40% | -16.52% | -26.63% | -13.34% | +8.17% | 99.44B | |
| -1.72% | +1.81% | +2.15% | +22.71% | +4.29% | +39.29% | +1.00% | +39.71% | +119.39% | 80.39B | |
| -1.25% | -8.22% | +0.61% | +270.08% | +578.54% | +648.32% | +160.68% | -42.76% | - | 79.89B | |
| +2.41% | +6.96% | +2.18% | -8.37% | -17.57% | -2.02% | +54.47% | +76.91% | +471.01% | 71.3B | |
| Average | -1.12% | +1.96% | +3.59% | +20.48% | +42.63% | +58.21% | +50.13% | +87.74% | +253.38% | 271.3B | |
| Weighted average by Cap. | -1.34% | +2.48% | +4.25% | +10.71% | +27.06% | +44.59% | +67.69% | +150.65% | +475.92% |
- Stock Market
- Stocks
- NOVN Stock
- NOVNEE Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
